28 September 2016 - Deborah Wilkes
Archived
Pfizer has decided not to split into two, publicly-traded companies "at this time". The US-based company has been weighing up the pros and cons of a split for several years.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.